OBS in Adolescent and Young Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
This study is currently recruiting participants.
Verified February 2013 by Meritage Pharma, Inc.
Sponsor:
Meritage Pharma, Inc.
Information provided by (Responsible Party):
Meritage Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT01642212
First received: July 13, 2012
Last updated: April 17, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |